KORU Medical Systems (KRMD) Stock Forecast, Price Target & Predictions
KRMD Stock Forecast
KORU Medical Systems stock forecast is as follows: an average price target of $3.75 (represents a 50.00% upside from KRMD’s last price of $2.50) and a rating consensus of 'Buy', based on 3 wall street analysts offering a 1-year stock forecast.
KRMD Price Target
The average price target for KORU Medical Systems (KRMD) is $3.75 based on 1-year price targets from 3 Wall Street analysts in the past 3 months, with a price target range of $4.50 to $3.00. This represents a potential 50.00% upside from KRMD's last price of $2.50.
KRMD Analyst Ratings
According to 3 Wall Street analysts, KORU Medical Systems's rating consensus is 'Buy'. The analyst rating breakdown for KRMD stock is 0 'Strong Buy' (0.00%), 2 'Buy' (66.67%), 1 'Hold' (33.33%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
KORU Medical Systems Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Jul 02, 2024 | Kyle Rose | Canaccord Genuity | $3.00 | $2.25 | 33.33% | 20.00% |
| Jan 06, 2023 | - | Piper Sandler | $4.50 | $3.70 | 21.62% | 80.00% |
| May 05, 2022 | Jason Bednar | Piper Sandler | $3.00 | $2.80 | 7.14% | 20.00% |
The latest KORU Medical Systems stock forecast, released on Jul 02, 2024 by Kyle Rose from Canaccord Genuity, set a price target of $3.00, which represents a 33.33% increase from the stock price at the time of the forecast ($2.25), and a 20.00% increase from KRMD last price ($2.50).
KORU Medical Systems Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | 1 | 1 |
| Avg Price Target | - | $3.00 | $3.00 |
| Last Closing Price | $2.50 | $2.50 | $2.50 |
| Upside/Downside | -100.00% | 20.00% | 20.00% |
In the current month, the average price target of KORU Medical Systems stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to KORU Medical Systems's last price of $2.50. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Aug 08, 2024 | Piper Sandler | Neutral | Neutral | Hold |
| Aug 08, 2024 | Piper Sandler | Overweight | Overweight | Hold |
| Jul 02, 2024 | Canaccord Genuity | Buy | Buy | Hold |
| Sep 07, 2023 | B. Riley | - | Buy | Initialise |
| Nov 10, 2022 | Piper Sandler | - | Overweight | Upgrade |
| Nov 10, 2022 | Canaccord Genuity | - | Buy | Upgrade |
KORU Medical Systems's last stock rating was published by Piper Sandler on Aug 08, 2024. The company gave KRMD a "Neutral" rating, the same as its previous rate.
KORU Medical Systems Financial Forecast
KORU Medical Systems Revenue Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | $7.00M | $6.94M | $7.39M | $7.34M | $7.76M | - | $6.24M | $6.49M | $6.04M | $5.53M | $5.43M | $4.06M | $6.08M | $7.71M | $6.33M | $6.22M | $6.62M |
| Avg Forecast | $11.72M | $10.98M | $11.35M | $10.55M | $10.07M | $9.43M | $9.44M | $8.95M | $7.96M | $7.68M | $7.57M | $7.48M | $6.94M | $7.93M | $6.90M | $7.44M | $7.38M | $6.78M | $6.29M | $6.06M | $6.06M | $5.42M | $5.20M | $5.10M | $4.69M | $7.11M | $6.53M | $6.20M | $5.36M | $5.48M |
| High Forecast | $11.90M | $11.15M | $11.53M | $10.72M | $10.23M | $9.57M | $9.59M | $9.09M | $8.09M | $7.73M | $7.69M | $7.60M | $7.05M | $8.05M | $7.01M | $7.55M | $7.50M | $6.89M | $6.29M | $6.08M | $6.09M | $5.45M | $5.22M | $5.12M | $4.71M | $7.14M | $6.56M | $6.22M | $5.38M | $5.50M |
| Low Forecast | $11.59M | $10.87M | $11.23M | $10.44M | $9.97M | $9.33M | $9.35M | $8.86M | $7.88M | $7.62M | $7.49M | $7.40M | $6.93M | $7.85M | $6.83M | $7.36M | $7.30M | $6.71M | $6.29M | $6.00M | $6.01M | $5.37M | $5.16M | $5.05M | $4.64M | $7.04M | $6.47M | $6.14M | $5.31M | $5.43M |
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 1 | 1 | 3 | 1 | 1 | 1 | 1 | 1 | - | - | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | - | - |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.88% | 1.01% | 0.99% | 1.00% | 1.14% | - | 1.03% | 1.07% | 1.11% | 1.06% | 1.06% | 0.87% | 0.86% | 1.18% | 1.02% | 1.16% | 1.21% |
KORU Medical Systems's average Quarter revenue forecast for Dec 23 based on 3 analysts is $6.94M, with a low forecast of $6.93M, and a high forecast of $7.05M. KRMD's average Quarter revenue forecast represents a -0.84% decrease compared to the company's last Quarter revenue of $7.00M (Sep 23).
KORU Medical Systems EBITDA Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 1 | 1 | 3 | 1 | 1 | 1 | 1 | 1 | - | - | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | - | - |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | $-1.56M | $-2.88M | $-2.79M | $-2.32M | $-1.36M | - | $-3.01M | $-1.99M | $-1.20M | $-1.26M | $-2.08M | $-1.06M | $451.77K | $3.76M | $878.86K | $1.80M | $2.64M |
| Avg Forecast | $-1.10M | $-1.03M | $-1.07M | $-994.55K | $-949.06K | $-888.50K | $-890.13K | $-843.95K | $-750.52K | $-724.00K | $-713.21K | $-4.84M | $-654.46K | $-747.33K | $-650.30K | $-3.83M | $-695.58K | $-1.78M | $-592.43K | $-3.03M | $-571.51K | $-1.62M | $-1.67M | $-2.10M | $-441.71K | $686.02K | $-2.99M | $678.58K | $-98.78K | $-516.28K |
| High Forecast | $-1.09M | $-1.02M | $-1.06M | $-984.19K | $-939.17K | $-879.25K | $-880.86K | $-835.16K | $-742.70K | $-718.33K | $-705.78K | $-3.88M | $-653.53K | $-739.55K | $-643.52K | $-3.06M | $-688.34K | $-1.43M | $-592.43K | $-2.42M | $-566.30K | $-1.30M | $-1.33M | $-1.68M | $-437.68K | $823.23K | $-2.39M | $814.30K | $-79.03K | $-511.57K |
| Low Forecast | $-1.12M | $-1.05M | $-1.09M | $-1.01M | $-963.89K | $-902.39K | $-904.04K | $-857.14K | $-762.25K | $-728.72K | $-724.36K | $-5.81M | $-664.68K | $-759.01K | $-660.46K | $-4.60M | $-706.45K | $-2.14M | $-592.43K | $-3.63M | $-573.75K | $-1.95M | $-2.00M | $-2.52M | $-443.44K | $548.82K | $-3.59M | $542.86K | $-118.54K | $-518.30K |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 2.09% | 4.43% | 0.73% | 3.34% | 0.76% | - | 0.99% | 3.49% | 0.74% | 0.76% | 0.99% | 2.39% | 0.66% | -1.26% | 1.30% | -18.18% | -5.12% |
1 analysts predict KRMD's average Quarter EBITDA for Dec 20 to be $-441.71K, with a high of $-437.68K and a low of $-443.44K. This is -197.77% lower than KORU Medical Systems's previous annual EBITDA (Sep 20) of $451.77K.
KORU Medical Systems Net Income Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 1 | 1 | 3 | 1 | 1 | 1 | 1 | 1 | - | - | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | - | - |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | - | $-1.37M | $-2.50M | $-2.41M | $-1.98M | $-1.23M | - | $-2.54M | $-1.07M | $-1.09M | $-1.12M | $-1.28M | $-834.63K | $249.18K | $-1.08M | $449.43K | $-80.26K | $651.81K |
| Avg Forecast | $105.37K | $-368.78K | $-286.32K | $-641.36K | $-916.23K | $-1.15M | $-1.26M | $-1.49M | $-1.83M | $-1.74M | $-1.97M | $-4.06M | $-1.83M | $-2.29M | $-2.60M | $-3.21M | $-2.60M | $-1.60M | $-2.91M | $-2.54M | $-1.55M | $-1.46M | $-1.50M | $-1.28M | $-260.04K | $336.39K | $-3.39M | $449.43K | $-159.14K | $228.35K |
| High Forecast | $107.51K | $-363.79K | $-282.44K | $-632.67K | $-903.82K | $-1.13M | $-1.24M | $-1.47M | $-1.81M | $-1.72M | $-1.94M | $-3.25M | $-1.37M | $-2.26M | $-2.56M | $-2.57M | $-2.57M | $-1.28M | $-2.91M | $-2.03M | $-1.53M | $-1.17M | $-1.20M | $-1.02M | $-256.96K | $403.66K | $-2.71M | $539.31K | $-127.31K | $229.51K |
| Low Forecast | $103.94K | $-376.27K | $-292.14K | $-654.39K | $-934.84K | $-1.17M | $-1.29M | $-1.52M | $-1.87M | $-1.78M | $-2.01M | $-4.87M | $-2.29M | $-2.34M | $-2.65M | $-3.85M | $-2.66M | $-1.93M | $-2.91M | $-3.05M | $-1.56M | $-1.75M | $-1.80M | $-1.53M | $-261.37K | $269.11K | $-4.07M | $359.54K | $-190.97K | $225.64K |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.60% | 0.96% | 0.75% | 0.76% | 0.76% | - | 1.00% | 0.69% | 0.75% | 0.75% | 1.00% | 3.21% | 0.74% | 0.32% | 1.00% | 0.50% | 2.85% |
KORU Medical Systems's average Quarter net income forecast for Dec 20 is $-260.04K, with a range of $-261.37K to $-256.96K. KRMD's average Quarter net income forecast represents a -204.36% decrease compared to the company's last Quarter net income of $249.18K (Sep 20).
KORU Medical Systems SG&A Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 1 | 1 | 3 | 1 | 1 | 1 | 1 | 1 | - | - | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | - | - |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | - | $4.62M | $5.30M | $5.43M | $4.76M | $4.83M | - | $5.49M | $4.88M | $3.90M | $4.09M | $4.99M | $2.99M | $3.08M | $3.20M | $2.76M | $2.80M | $2.44M |
| Avg Forecast | $7.34M | $6.88M | $7.11M | $6.61M | $6.31M | $5.91M | $5.92M | $5.61M | $4.99M | $4.81M | $4.74M | $4.69M | $4.35M | $4.97M | $4.32M | $6.95M | $4.62M | $5.72M | $3.94M | $5.49M | $3.80M | $5.20M | $3.26M | $4.99M | $2.94M | $4.31M | $4.09M | $2.85M | $3.36M | $3.43M |
| High Forecast | $7.45M | $6.99M | $7.22M | $6.71M | $6.41M | $6.00M | $6.01M | $5.70M | $5.07M | $4.84M | $4.82M | $4.76M | $4.42M | $5.05M | $4.39M | $8.34M | $4.70M | $6.87M | $3.94M | $6.59M | $3.81M | $6.24M | $3.27M | $5.99M | $2.95M | $5.17M | $4.11M | $3.42M | $3.37M | $3.45M |
| Low Forecast | $7.26M | $6.81M | $7.04M | $6.54M | $6.24M | $5.85M | $5.86M | $5.55M | $4.94M | $4.78M | $4.69M | $4.64M | $4.34M | $4.92M | $4.28M | $5.56M | $4.58M | $4.58M | $3.94M | $4.39M | $3.76M | $4.16M | $3.23M | $3.99M | $2.91M | $3.45M | $4.06M | $2.28M | $3.33M | $3.40M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.93% | 1.23% | 0.78% | 1.03% | 0.84% | - | 1.00% | 1.28% | 0.75% | 1.25% | 1.00% | 1.02% | 0.71% | 0.78% | 0.97% | 0.83% | 0.71% |
KORU Medical Systems's average Quarter SG&A projection for Dec 23 is $4.35M, based on 3 Wall Street analysts, with a range of $4.34M to $4.42M. The forecast indicates a -5.91% fall compared to KRMD last annual SG&A of $4.62M (Sep 23).
KORU Medical Systems EPS Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 1 | 1 | 3 | 1 | 1 | 1 | 1 | 1 | - | - | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | - | - |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | $-0.03 | $-0.05 | $-0.05 | $-0.04 | $-0.03 | - | $-0.06 | $-0.02 | $-0.02 | $-0.03 | $-0.03 | $-0.02 | $0.01 | $-0.03 | $0.01 | $-0.00 | $0.02 |
| Avg Forecast | - | $-0.01 | $-0.01 | $-0.01 | $-0.02 | $-0.03 | $-0.03 | $-0.03 | $-0.04 | $-0.04 | $-0.04 | $-0.04 | $-0.04 | $-0.05 | $-0.06 | $-0.05 | $-0.06 | $-0.05 | $-0.06 | $-0.06 | $-0.03 | $-0.02 | $-0.02 | $-0.01 | $-0.01 | $0.02 | $0.02 | $0.02 | $0.01 | $0.01 |
| High Forecast | - | $-0.01 | $-0.01 | $-0.01 | $-0.02 | $-0.02 | $-0.03 | $-0.03 | $-0.04 | $-0.04 | $-0.04 | $-0.04 | $-0.03 | $-0.05 | $-0.06 | $-0.05 | $-0.06 | $-0.05 | $-0.06 | $-0.06 | $-0.03 | $-0.02 | $-0.02 | $-0.01 | $-0.01 | $0.02 | $0.02 | $0.02 | $0.01 | $0.01 |
| Low Forecast | - | $-0.01 | $-0.01 | $-0.01 | $-0.02 | $-0.03 | $-0.03 | $-0.03 | $-0.04 | $-0.04 | $-0.04 | $-0.04 | $-0.05 | $-0.05 | $-0.06 | $-0.05 | $-0.06 | $-0.06 | $-0.06 | $-0.06 | $-0.03 | $-0.02 | $-0.02 | $-0.01 | $-0.01 | $0.02 | $0.02 | $0.02 | $0.01 | - |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.60% | 0.97% | 1.06% | 0.77% | 0.50% | - | 1.00% | 0.71% | 1.01% | 1.26% | 4.35% | 3.35% | 0.51% | -1.33% | 0.50% | -0.20% | 3.30% |
According to 1 Wall Street analysts, KORU Medical Systems's projected average Quarter EPS for Dec 20 is $-0.01, with a low estimate of $-0.01 and a high estimate of $-0.01. This represents a -156.94% decrease compared to KRMD previous annual EPS of $0.01 (Sep 20).
KRMD Forecast FAQ
Is KORU Medical Systems a good buy?
Yes, according to 3 Wall Street analysts, KORU Medical Systems (KRMD) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 2 'Buy' recommendations, accounting for 66.67% of KRMD's total ratings.
What is KRMD's price target?
KORU Medical Systems (KRMD) average price target is $3.75 with a range of $3 to $4.5, implying a 50.00% from its last price of $2.5. The data is based on 3 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will KORU Medical Systems stock go up soon?
According to Wall Street analysts' prediction for KRMD stock, the company can go up by 50.00% (from the last price of $2.5 to the average price target of $3.75), up by 80.00% based on the highest stock price target, and up by 20.00% based on the lowest stock price target.
Can KORU Medical Systems stock reach $4?
KRMD's highest twelve months analyst stock price target of $4.5 supports the claim that KORU Medical Systems can reach $4 in the near future.
What are KORU Medical Systems's analysts' financial forecasts?
KORU Medical Systems's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $37.9M (high $38.49M, low $37.5M), average EBITDA is $-3.572M (high $-3.534M, low $-3.627M), average net income is $-4.81M (high $-4.745M, low $-4.908M), average SG&A $23.74M (high $24.11M, low $23.5M), and average EPS is $-0.105 (high $-0.104, low $-0.107). KRMD's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $44.6M (high $45.3M, low $44.14M), average EBITDA is $-4.203M (high $-4.16M, low $-4.269M), average net income is $-1.191M (high $-1.171M, low $-1.219M), average SG&A $27.94M (high $28.38M, low $27.65M), and average EPS is $-0.026 (high $-0.0256, low $-0.0266).
Did the KRMD's actual financial results beat the analysts' financial forecasts?
Based on KORU Medical Systems's last annual report (Dec 2022), the company's revenue was $27.9M, beating the average analysts forecast of $26.51M by 5.24%. Apple's EBITDA was $-10.154M, beating the average prediction of $-6.099M by 66.49%. The company's net income was $-8.661M, missing the average estimation of $-9.659M by -10.33%. Apple's SG&A was $20.61M, beating the average forecast of $19.78M by 4.20%. Lastly, the company's EPS was $-0.19, missing the average prediction of $-0.231 by -17.90%. In terms of the last quarterly report (Sep 2023), KORU Medical Systems's revenue was $7M, missing the average analysts' forecast of $7.93M by -11.68%. The company's EBITDA was $-1.562M, beating the average prediction of $-747K by 109.02%. KORU Medical Systems's net income was $-1.368M, missing the average estimation of $-2.291M by -40.27%. The company's SG&A was $4.62M, missing the average forecast of $4.97M by -6.93%. Lastly, the company's EPS was $-0.03, missing the average prediction of $-0.05 by -40.00%